Red Sage Marketing Director Michelle Stark Joins HudsonAlpha Navigate Mentorship Program
The HudsonAlpha Institute for Biotechnology has launched a new mentoring program to help strengthen biotech and life sciences entrepreneurs. The Navigate program is modeled after MIT’s Venture Mentoring Service program, which has been successfully mentoring entrepreneurs for more than 20 years. Red Sage Communications’ own Marketing Director, Michelle Stark, is among Navigate’s first class of mentors. HudsonAlpha describes the mentor group as a “who’s-who of business executives, serial entrepreneurs and civic leaders.”
The current mentors are:
-Paul Gierow, Founder, GATR Technologies
-Matthew Parker, PhD, Associate, Maynard Cooper
-Kevin Gold, Operating Partner, Integrated Openings Solutions
-Steve Hettinger, Former engineer, manager and public servant
-Irma Tuder, Founder and CEO, Analytical Services, Inc.
-Patrick Shields, Senior Vice President, Morgan Stanley
-Gary Bolton, Vice President Global Marketing, Adtran
-Barry Derrick, Product Manager, Adtran
-Danny Windham, COO, HudsonAlpha Institute for Biotechnology
-Peggy Sammon, CEO, GeneCapture
-Rex Vaughn, President, Madison County Farmers Federation
-Michelle Stark, Marketing Director, Red Sage Communications
-Brian Pollock, CEO and Founder, Kailos Genetics
-Tom Young, CEO Kord Technologies
-Richard Marsden, Shareholder, Maynard Cooper
Through careful selection, Navigate matches growing entrepreneurs with teams of c-suite executives, experienced entrepreneurs and regional subject matter experts to provide them a group of confidential and conflict-free advisors. After completing its pilot phase, the program will later be available to companies across North Alabama. Companies must be involved in biotech or life sciences for consideration. If you are interested in learning more about Navigate, email email@example.com.
HudsonAlpha Institute for Biotechnology is a nonprofit institute dedicated to developing and applying scientific advances to health, agriculture, learning, and commercialization. Opened in 2008, HudsonAlpha’s vision is to leverage the synergy between discovery, education, medicine, and economic development in genomic sciences to improve the human condition around the globe.